Entry |
|
Name |
Ozagrel hydrochloride hydrate (JAN); Ozagrel hydrochloride; Ozagrel (TN) |
Formula |
C13H12N2O2. HCl. H2O
|
Exact mass |
282.0771
|
Mol weight |
282.7228
|
Structure |
|
Simcomp |
|
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
|
Remark |
Therapeutic category: | 4490 |
Product (DG01256): | D01683<JP> D01684<JP> |
|
Efficacy |
Antiasthmatic, Airway hyperreactivity inhibitor, Thromboxane A2 (TXA2) synthase inhibitor |
Target |
|
Pathway |
|
Interaction |
|
Structure map |
|
Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
449 Miscellaneous
4490 Miscellaneous
D01683 Ozagrel hydrochloride hydrate (JAN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
DG01256 Ozagrel
D01683 Ozagrel hydrochloride hydrate
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
Thromboxane-A synthase
TBXAS1 (CYP5A1)
D01683 Ozagrel hydrochloride hydrate (JAN) <JP>
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
DG01256 Ozagrel
|
Other DBs |
|
KCF data |
ATOM 19
1 N4y N 24.8993 -15.9855
2 C8x C 25.3377 -17.3182
3 C8x C 26.0391 -15.1496
4 C1b C 23.6718 -15.2958
5 N5x N 26.7405 -17.3182
6 C8x C 27.1789 -15.9855
7 C8y C 22.4677 -16.0206
8 C8x C 22.4911 -17.4291
9 C8x C 21.2343 -15.3366
10 C8x C 21.2811 -18.1482
11 C8x C 20.0771 -16.0614
12 C8y C 20.1122 -17.4643
13 C2b C 18.9022 -18.1831
14 C2b C 17.6826 -17.4992
15 C6a C 16.4802 -18.2135
16 O6a O 15.2604 -17.5294
17 O6a O 16.4278 -19.6118
18 X Cl 29.7155 -16.9975
19 O0 O 33.1850 -16.9854
BOND 18
1 2 5 2
2 3 6 2
3 4 7 1
4 7 8 2
5 7 9 1
6 8 10 1
7 9 11 2
8 10 12 2
9 12 13 1
10 5 6 1
11 11 12 1
12 13 14 2
13 14 15 1
14 1 2 1
15 15 16 1
16 1 3 1
17 15 17 2
18 1 4 1
|